Bank of America’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-365,383
Closed -$5.33M 8197
2023
Q1
$5.33M Buy
365,383
+296,288
+429% +$4.19M ﹤0.01% 3481
2022
Q4
$504K Buy
69,095
+1,090
+2% +$7.69K ﹤0.01% 5371
2022
Q3
$471K Buy
68,005
+250
+0.4% +$1.87K ﹤0.01% 5453
2022
Q2
$473K Sell
67,755
-1,024
-1% -$7.99K ﹤0.01% 5473
2022
Q1
$569K Buy
68,779
+37,542
+120% +$339K ﹤0.01% 5742
2021
Q4
$337K Buy
31,237
+13,157
+73% +$142K ﹤0.01% 6167
2021
Q3
$218K Buy
18,080
+17,946
+13,393% +$203K ﹤0.01% 6245
2021
Q2
$2K Buy
+134
New +$1.66K ﹤0.01% 7570

Bank of America's AMYT Position: Q2 2023 in Review

Bank of America sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 365,383 shares — an estimated $5.33M sold.

Bank of America first reported a position in AMYT in Q2 2021 and held it in 8 quarters. The position peaked at $5.33M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Bank of America reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Bank of America sold 365,383 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $5.33M.
  • Bank of America first reported a position in Amryt Pharma plc American Depositary Shares in Q2 2021 and held it in 8 quarters.
  • Bank of America's Amryt Pharma plc American Depositary Shares position peaked at $5.33M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Bank of America's 13F filing for Q2 2023, filed 14 Aug 2023.